Dominion Energy Inc vs Heron Therapeutics Inc — how do they compare? Dominion Energy Inc trades at $68.36 (market cap $59.06B), while Heron Therapeutics Inc trades at $0.32 (market cap $63.41M). The key difference: Dominion Energy Inc is far larger — about 931.4× Heron Therapeutics Inc's market cap, and Dominion Energy Inc pays a 3.98% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| D | HRTX | |
|---|---|---|
Market Cap | $59.06B | $63.41M |
Sector | Utilities | Health |
52-Week High | $71.67 | $1.49 |
52-Week Low | $57.08 | $0.32 |
Enterprise Value | $113.18B | $161.31M |
Dividend Yield | 3.98% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Heron Therapeutics (HRTX) trades at $0.49, down 1.64% today, with a bearish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed earnings expectations with a $0.03 loss per share. Despite negative net income margins, HRTX maintains strong analyst support with 94.7% buy ratings. Recent news highlights patent litigation developments and quarterly earnings underperformance.
HRTX faces significant fundamental challenges with persistent losses and declining revenue projections, though analyst consensus remains overwhelmingly bullish. Investment opportunity exists if the company can achieve profitability and meet growth targets, but risks include ongoing operational losses, competitive pressures, and execution challenges in the biotechnology sector.
Trailing returns across standard periods
Latest headlines on both assets
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Read more on D →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →